Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:NSTG

NanoString Technologies (NSTG) Stock Price, News & Analysis

About NanoString Technologies Stock (NASDAQ:NSTG)

Key Stats

Today's Range
N/A
50-Day Range
$0.05
$0.80
52-Week Range
N/A
Volume
23.06 million shs
Average Volume
34.54 million shs
Market Capitalization
$5.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Hold

Company Overview

NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

NanoString Technologies Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
39th Percentile Overall Score

NSTG MarketRank™: 

NanoString Technologies scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    NanoString Technologies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    NanoString Technologies has received no research coverage in the past 90 days.

  • Read more about NanoString Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for NanoString Technologies are expected to grow in the coming year, from ($3.05) to ($1.98) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NanoString Technologies is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NanoString Technologies is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for NSTG.
  • Dividend Yield

    NanoString Technologies does not currently pay a dividend.

  • Dividend Growth

    NanoString Technologies does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for NSTG.
    Receive NSTG Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for NanoString Technologies and its competitors with MarketBeat's FREE daily newsletter.

    NSTG Stock News Headlines

    Protect Your Bank Account with THESE 4 Simple Steps
    Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
    See More Headlines

    NSTG Stock Analysis - Frequently Asked Questions

    NanoString Technologies, Inc. (NASDAQ:NSTG) issued its quarterly earnings data on Thursday, August, 3rd. The biotechnology company reported ($0.92) EPS for the quarter, missing analysts' consensus estimates of ($0.70) by $0.22. The company's revenue was up 37.1% on a year-over-year basis.

    Based on aggregate information from My MarketBeat watchlists, some other companies that NanoString Technologies investors own include Xtrackers California Municipal Bond ETF (CA), Tesla (TSLA), BlackRock (BLK), NVIDIA (NVDA), Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG) and Meta Platforms (META).

    Company Calendar

    Last Earnings
    8/03/2023
    Today
    10/15/2024
    Fiscal Year End
    12/31/2024

    Industry, Sector and Symbol

    Sector
    Medical
    Industry
    Medical Instruments & Supplies
    Sub-Industry
    N/A
    Current Symbol
    NASDAQ:NSTG
    Employees
    550
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $8.00
    High Stock Price Target
    $8.00
    Low Stock Price Target
    $8.00
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    4 Analysts

    Profitability

    Net Income
    $-159,540,000.00
    Net Margins
    -102.44%
    Pretax Margin
    -102.30%

    Debt

    Sales & Book Value

    Annual Sales
    $127.26 million
    Book Value
    $0.98 per share

    Miscellaneous

    Free Float
    46,626,000
    Market Cap
    $5.07 million
    Optionable
    Optionable
    Beta
    1.24
    10 Best Stocks to Own in 2024 Cover

    Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

    Get This Free Report

    This page (NASDAQ:NSTG) was last updated on 10/15/2024 by MarketBeat.com Staff
    From Our Partners